1. Must not have acute promyelocytic leukemia (M3 classification)

2. Must not have any other active systemic malignancies.

3. Must not have inaspirable bone marrow.

4. Must not have received previous chemotherapy (except hydroxyurea) for any myeloid disorder.

5. Must not have chronic respiratory disease that requires continuous oxygen use.

6. Must not have received any experimental drug within 4 weeks before randomization.

7. Must not be a candidate for a bone marrow or stem cell transplant within 12 weeks after randomization.

8. Must not have known HIV.

Trial of Decitabine in Patients With Acute Myeloid Leukemia